Admixture Mapping of Quantitative Trait Loci for BMI in African Americans: Evidence for Loci on Chromosomes 3q, 5q, and 15q by Basu, Analabha et al.
1226 VOLUME 17 NUMBER 6 | JUNE 2009 | www.obesityjournal.org
articles nature publishing group
Genetics
IntroductIon
Although obesity is an individual clinical condition, it is 
increasingly viewed as a serious and growing worldwide  public 
health problem. Obesity is believed to predispose to all the 
major killer diseases such as type 2 diabetes, cardiac disorders, 
hypertension, stroke, metabolic diseases, and even some forms 
of cancer (1). The prevalence of obesity has been continually 
rising for two decades (2). A common and inexpensive sur-
rogate to measure obesity is BMI, defined as the ratio of weight 
in kilograms to squared height in meters. The variable BMI 
has its limitations, as it may be differentially affected by lean 
mass and bone content, which vary among population groups. 
However, an advantage of analyzing BMI is that it is a continu-
ously measured trait, which generally provides greater power 
in searching for explanatory covariates than overweight or 
obesity defined by arbitrary cutoffs.
Though it is largely believed that excessive energy intake and 
a sedentary lifestyle of the developed world has been the major 
cause behind the obesity epidemic (3), other factors including 
genetic predisposition are also deemed responsible. Genetic 
 factors contribute significantly to obesity (4), with heritability 
estimates of BMI ranging from 30 to 70% (4,5). In the present 
sample, estimated heritability, calculated for the three different 
networks, ranged between 45 and 62% (6,7). There have been 
numerous efforts to identify genes and chromosomal regions 
responsible for BMI, using genome-wide linkage and association 
analysis (5). Although a number of genes with rare mutations are 
known to lead to increased BMI and obesity, such as the melano-
cortin 4 receptor gene (8), most recently convincing evidence 
for the role of a common polymorphism in the FTO and PCSK1 
gene with a modest effect on BMI has been presented (9,10).
New world admixed populations provide unique oppor-
tunities for genetic admixture mapping studies (11–13). The 
African American (AA) population of the United States is 
typically represented by admixture of European and African 
ancestral genomes in different proportions with some spatial 
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variation (14–16). Several studies have examined the correla-
tion between European (or African) ancestry in AAs and BMI 
or obesity (17–19). Three previous studies have demonstrated a 
positive association between African ancestry and BMI (17), a 
positive association of European ancestry with obesity- related 
traits (16), and no correlation of ancestry with BMI (19). In 
a prior analysis of the AA participants in the Family Blood 
Pressure Program (FBPP) (20), we found a positive correla-
tion between BMI and individual African ancestry estimated 
from genome-wide microsatellite markers (16). In this study, 
we now present results of an analysis examining the correla-
tion of BMI with estimated ancestry proportions at each of 
284 marker loci among 1,344 unrelated AA subjects from the 




The FBPP is a large multicenter genetic study of high blood pres-
sure and related conditions in multiple racial/ethnic groups, includ-
ing European Americans (EAs), AAs, Mexican Americans, Asians, 
and Asian Americans (20). It includes four component networks: 
GenNet, GENOA, HyperGEN, and SAPPHIRE. GenNet, GENOA, 
and HyperGEN independently collected samples from EA and AA 
families. GenNet sampled AA and EA nuclear families in Maywood, 
Illinois and Tecumseh, Michigan, respectively, through identifica-
tion of a young middle-aged proband with elevated blood pressure. 
GENOA sampled AA sibships containing sibling pairs with hyper-
tension from Jackson, Mississippi and EA sibships with an affected 
proband from Rochester, Minnesota. HyperGEN recruited AA and 
EA hypertensive siblings and random unrelated individuals from 
five field centers (AA from Birmingham, Alabama and Forsyth 
County, North Carolina; EA from Salt Lake City, Utah, Minneapolis, 
Minnesota, Framingham, Massachusetts, and Forsyth County, North 
Carolina). All individuals who participated in the FBPP gave informed 
consent; the Institutional Review Board at each clinic site approved all 
protocols, and a Certificate of Confidentiality was obtained from the 
Federal Government for this study.
All the individuals we included in the study were unrelated AA from 
field centers of GenNet, GENOA, and HyperGEN. Race/ethnicity infor-
mation was obtained by self-description. To maximize the number of 
unrelated individuals in our sample, whenever possible we selected 
unrelated founder individuals, otherwise one randomly selected indi-
vidual per family. Our final sample of 1,344 individuals consisted of 280 
individuals who were sampled by the GenNet network, 349 individuals 
sampled by the GENOA network, and 715 individuals sampled by the 
HyperGEN network.
Genotyping
DNA was extracted from whole blood by standard methods by each of 
the four FBPP networks and was sent to the US National Heart, Lung, 
and Blood Institute’s Mammalian genotyping service in Marshfield, 
Wisconsin, for genotyping. Screening set 8 (372 highly polymorphic 
microsatellite markers with an average map distance of 10 cM) was used 
for all four networks.
statistical analysis
We used the computer program STRUCTURE (21,22) to estimate 
genome-wide, as well as site-specific ancestries in all AA participants. 
The linkage model was used, with genetic distance between markers 
specified according to the Marshfield map. In each analysis, the MCMC 
algorithm was run for 100,000 steps of burn-in followed by another 
100,000 steps.
For the analysis of 1,344 FBPP AAs, we assumed a two-ancestral 
populations’ model reflecting African and European ancestry. In these 
subjects, there was evidence of only very modest Native American 
ancestry (<1% on average), at best. We also included 1,378 unrelated 
non-Hispanic white participants from the FBPP as well as 127 African 
individuals from the Human Genome Diversity Project (23). This latter 
set of individuals had been genotyped at >300 short tandem repeats 
at the time of our analysis, and we included genotypes at 284 markers 
which were also genotyped in the FBPP individuals.
At each locus we calculated, for each individual, an ancestry 
 deviation defined as the estimated ancestry at that location minus 
the background ancestry estimated from the genome-wide markers 
for that individual.
Specifically, let qki l,  be the locus-specific ancestry of individual 
i (i = 1, 2, …, N) at marker locus l (l = 1, 2, …, L) estimated from 
STRUCTURE. We compute the overall (genome-wide) individual 
admixture qki( ) for the individual i as the average individual admixture 
per locus:
We computed the ancestry difference at each locus, using the 
genome-wide Individual Ancestry (IA) as baseline. Specifically for 
individual i, the ancestry difference for ancestral population k at marker 
l is defined as:
Note that we have dropped the suffix k pertaining to the population 
from which the ancestry coefficients are derived. The variable xli was then 
used as the primary independent variable in a linear regression model 
with BMI (transformed) as the dependent variable.
As we have only two ancestral populations, each individual’s  African 
(IA-AF) and European (IA-EU) ancestry sum to one. Therefore, 
IA-EU = [1 − (IA-AF)], and the same is true for the ancestry devia-
tion at a particular location from an individual’s genome-wide average 
ancestry. Thus, for any individual, the African and European ancestry 
deviations at a specific locus sum to one and are completely collinear 
in a regression analysis. Hence, only one term was included. Also, any 
regression result for European ancestry deviation is identical to a result 
using African ancestry deviation instead, with the sign of the regression 
coefficient in the opposite direction. Without loss of generality, we have 
used the excess European ancestry as our independent variable, and 
interpreted our findings based on that.
Age, sex, and network were also included as covariates in this 
analysis, if significant. Because of a highly significant sex effect, we 
also allowed for interaction between sex and network in the covari-
ate adjustment. The standardized regression coefficient of xli, defined 
as rli, is distributed as asymptotically normal and was used to assess 
statistical significance.
To account for multiple testing (284 markers), we performed a 
 permutation analysis in which we randomly reassigned the BMI and 
covariate data to individuals, whose genetic ancestry estimates for 
the 284 marker locations remained intact. This procedure preserved 
the correlation  structure of the markers and the correlation structure 
of BMI and  covariates, but dissociated the relationship between the 
markers and phenotypes. For each permuted data set, we performed 
the same regression analysis of BMI on excess ancestry at each marker 
location, as was done for the original data, and obtained the most 
extreme values (positive and negative) of rl (the Z-score statistics). 
One thousand permutations were performed. To derive P values 
adjusted for multiple testing, we determined the percentage of times 
out of 1,000 permutations that an observed value of rl was exceeded 























Sample demographics are given in Table 1. There were 878 
women and 466 men. The subjects from the GenNet network 
were the youngest (average age 41) and subjects from GENOA 
the oldest (average age 60), while the HyperGen subjects were in 
between (average age 51). Average BMIs were generally higher 
in women than men, and there was little variation in BMI 
among networks. Average European ancestry varied modestly 
among the three networks, as was previously observed (16).
The distribution of BMI for the 1,344 unrelated individuals 
in this study was positively skewed. Neither the 1/BMI nor the 
loge(BMI) transformation, generally found in the literature, 
provided a satisfactory normalization of the data. However, a 
loglog transformation of BMI did make the distribution nor-
mal (Supplementary Figure S1). The trait LLBMI, which was 
defined as the loglog transformation of the original BMI, was 
strongly affected by sex and study center but not age (or age2) 
when tested by ANOVA (Table 2).
After adjusting the LLBMI values for sex, study network, and 
the interaction between sex and network, we regressed it on 
excess European ancestry (xl) at each locus l (l = 1–284). The 
ratio (rl) of the estimated slope of the regression (bl) divided 
by its standard error (sl) is asymptotically normal. We looked 
at regions with high absolute value of rl. A positive value of 
the gradient bl (and hence rl) at the marker locus l implies that 
BMI is positively correlated with excess European ancestry 
(and negatively correlated with African ancestry) at that locus 
while a negative value of rl implies that BMI is negatively cor-
related with European ancestry (and positively correlated with 
African ancestry) at that locus.
A Quantile–Quantile (Q–Q) plot of the rl values against a 
normal distribution reveals that the fit is good except for the 
tails. There is a significant bulge in the right tail and at least two 
points in the left tail of the distribution also appear to be out-
liers (Figure 1). Table 3 lists all markers for which the absolute 
value of the ratio rl was >1.96 (corresponding to a two-sided 
unadjusted P value of 0.05). There are 11 points in the left tail 
and 13 in the right tail with absolute values >1.96, compared to 
7 expected in each tail by chance. The three most extreme points 
in the left tail of the distribution are three consecutive markers, 
all from chromosome region 15q25.3–26.2. The next locus lying 
posterior to 15q26.2 at 15q26.3 (D15S642 or GATA27A03) also 
has a low rl value of −2.12. The points that constitute the bulge 
in the right tail of the distribution are markers primarily from 
chromosome regions 3q28–29 and 5q14–23. There are also sev-
eral points from the region 16p11.2–13.1.
To check the significance of our findings, we ran a permu-
tation test in which we randomly assigned the phenotype 
and the related covariates to an individual’s genotype, and 
regressed it on the locus specific excess European ancestry (xl) 
(see Methods). In 1,000 permutations, the minimum of 284 
rl scores only once crossed −3.14 and never crossed −3.43. 
The maximum also crossed 2.95 only once. Hence, the results 
associated with the markers D15S816, D15S652, and D3S1311 
have empirical adjusted P values <0.002. We have done some 
additional analyses to show that these values are not due to 
“outlier” effects. Specifically, we looked at the scatter plot of 
individual excess European ancestry and LLBMI to search 
for outlier points with very high (or low) individual excess 
European ancestry at a locus coupled with a very high (or low) 
BMI value, which could distort the results. However, no such 
“outlier” points were identified (Supplementary Figure S2).
table 1 demographics of study sample
GenNet GENOA HyperGEN
Women Men Women Men Women Men
Number of individuals 164 116 241 108 473 242
Average (BMI) 31.71 ± 8.6 27.38 ± 6.4 31.67 ± 7.3 29.37 ± 4.6 34.28 ± 8.3 29.34 ± 6.6
Average (age) 41.97 ± 12.6 40.75 ± 11.8 59.71 ± 9.8 60.85 ± 9.1 50.51 ± 12.6 50.83 ± 13.2
European ancestry (%) 13.48 13.87 14.86 14.76 12.53 13.06








Age 1 0.0045 0.0045 1.0493 0.30585
Sex 1 0.4082 0.4082 95.0617 <2.2 × 10−16
Network 2 0.1116 0.0558 12.9926 2.579 × 10−6
Sex × 
network
2 0.0336 0.0168 3.9140 0.02019
Residuals 1,337 5.7415 0.0043

















Figure 1 Q–Q plot comparing rl with a standard normal distribution.
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Because of the strong sex effect on BMI in our sample, we also 
looked to see if there were sex differences in our ancestry map-
ping results. For the significant locations we identified, there 
were no significant differences in the regression estimates on 
local ancestry between men and women, as tested by an interac-
tion term between sex and ancestry in the regression analysis. 
Hence, the effects we observed do not appear to be sex-specific.
dIscussIon
This study represents the first large-scale attempt to identify 
loci underlying an obesity-related trait (BMI) by admixture 
mapping in AAs, and our results were quite promising. The 
ancestry Z-score distribution revealed outliers in both tails, 
but otherwise a good fit to a normal distribution. Table 4 lists 
24 markers out of 284 (8.5%) compared to the expected 14 
(5%). If we take |rl| > 2.5 as our cutoff instead of 1.96, there are 
nine (3.2%) markers above that threshold although we expect 
only 3.5 (1.24%). If we look at the markers in Table 3 with 
further detail, we find that the markers are mostly clustered 
into six different regions of the genome (Table 4) at 1q, 7p, 
and 15q (excess African ancestry) and 3q, 5q, and 16p (excess 
European ancestry). Eight of the nine markers for which the rl 
values are >2.5 (shown in boldface) are from the three regions, 
15q25.3–q26.3, 3q28–q29, and 5q14.1–5q32.
Among the six identified locations, the regions 7p12.3–
7p14.3 and 16p11.2–16p13.1 have the lowest statistical 
 significance. However, the region on 7p is known to harbor 
the growth-related growth hormone–releasing hormone 
receptor (GHRHR) and isolated growth hormone deficiency 
(IGHD) genes. Mutations in these genes have been generally 
associated with lower BMI (24). Mouse polygenic models of 
obesity studying a quantitative trait locus for abdominal fat 












 D15S816 15q26.2 (100.59) −5.784 −3.433 GATA73F01
 D15S652 15q26.1 (90.02) −3.572 −3.139 ATA24A08
 D15S655 15q25.3 (82.84) −2.559 −2.493 ATA28G05
 Unknown 1q32.2 (226.16) −4.027 −2.225 GATA124F08
 D1S235 1q42.3 (254.64) −1.632 −2.168 AFM203YG9
 D1S3462 1q42.2 (247.23) −2.081 −2.167 ATA29C07
 D15S642 15q26.3 (122.14) −3.235 −2.120 GATA27A03
 D4S1652 4q35.2 (208.07) −2.236 −2.046 GATA5B02
 D1S549 1q41 (239.66) −2.423 −2.036 GATA4H09
 D7S1818 7p12.3 (69.56) −2.865 −2.008 GATA24D12
 D7S817 7p14.3 (50.29) −2.512 −1.990 GATA13G11
Right tail
 D5S1480 5q32 (147.49) 5.320 1.977 ATA23A10
 D5S1501 5q14.1 (85.25) 2.438 2.109 GATA52A12
 D16S769 16p12.1 (50.6) 2.756 2.233 GATA71H05
 D16S753 16p11.2 (57.79) 3.135 2.270 GGAA3G05
 D16S748 16p13.13 (22.65) 2.464 2.367 ATA3A07
 D5S1725 5q14.3 (97.82) 1.555 2.369 GATA89G08
 D16S764 16p13.11 (29.97) 2.815 2.418 GATA42E11
 D5S1505 5q23.1 (129.83) 8.552 2.507 GATA62A04
 D5S816 5q31.1–31.2 (139.33) 7.821 2.591 GATA2H09
 D11S1984 11p15.5 (2.11) 4.273 2.615 GGAA17G05
 D3S2418 3q28–29 (215.84) 4.325 2.678 ATA22E01
 D5S2501 5q22.1 (116.98) 5.953 2.733 GATA68A03
 D3S1311 3q29 (224.88) 4.282 2.950 AFM254VE1
table 4 Most significant chromosomal regions showing 
African or european ancestry association with BMI
Location and 
distance (cM) DNAME Marker name Estimated (rl)
1q32.2–1q42.3
 226.16 Unknown GATA124F08 −2.225
 239.66 D1S549 GATA4H09 −2.036
 247.23 D1S3462 ATA29C07 −2.167
 254.64 D1S235 AFM203YG9 −2.168
3q28–29
 215.84 D3S2418 ATA22E01 2.678
 224.88 D3S1311 AFM254VE1 2.950b
5q14.1–5q32
 85.25 D5S1501 GATA52A12 2.109
 97.82 D5S1725 GATA89G08 2.369
 116.98 D5S2501 GATA68A03 2.733
 129.83 D5S1505 GATA62A04 2.507
 139.33 D5S816 GATA2H09 2.591
 147.49 D5S1480 ATA23A10 1.977
7p14.3–7p12.3
 50.29 D7S817 GATA13G11 −1.990
 57.79 D7S2846 GATA31A10 −1.789a
 69.56 D7S1818 GATA24D12 −2.008
15q25.3–q26.3
 82.84 D15S655 ATA28G05 −2.493
 90.02 D15S652 ATA24A08 −3.139b
 100.59 D15S816 GATA73F01 −3.433b
 122.14 D15S642 GATA27A03 −2.120
16p13.1–16p11.2
 22.65 D16S748 ATA3A07 2.367
 29.97 D16S764 GATA42E11 2.418
 43.89 D16S403 AFM049XD2 1.899a
 50.6 D16S769 GATA71H05 2.233
 57.79 D16S753 GGAA3G05 2.270
Markers for which the rl values are >2.5 are shown in boldface.
aLocus does not have |  rl | > 1.96 but is listed here because it lies between 
two points in the same region having | rl | > 1.96. 
bLocus is significant after the 
 permutation test.
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have found a putative human homologue in region 7p13–p12 
(ref. 25). It may be noted here that the rl values of the region 
7p are negative, implicating a positive association of BMI 
with excess African ancestry at that locus. In a recent  linkage 
study among 769 subjects from 182 families in Africa, the 
marker D7S817 has been linked to BMI with a  logarithm of 
odds (lod) score of 3.83 (ref. 26). In another linkage study 
consisting of 342 families, D7S1818 was associated with a lod 
score of 2.2 for BMI trends from childhood to  adulthood (27). 
The marker D16S764, which has the highest rl value of 2.41 
among all the markers in the 16p region, has been shown pre-
viously to be both modestly linked (lod 2.45) and associated 
(P < 0.0006) with BMI (28). The sample in the above study 
was composed of 893 white sibpairs, which may be consist-
ent with the high positive value of rl. Several  markers in this 
region have also been shown to be linked to BMI and other 
obesity-related phenotypes with lod scores ranging from 
1.7 to 3.21. All these studies were reported among different 
 populations of European descent (28,29).
The region 1q32.2–1q42.3 contains the angiotensinogen 
(AGT) gene. Numerous previous studies (30–33) have found 
association between this gene and obesity-related pheno-
types, including BMI. Keeping in mind the negative rl values 
of  markers in this region (African excess), the fact that linkage 
of this region with obesity-related phenotypes was found only 
among black families may be of particular interest.
The six consecutive markers on chromosome five with high 
positive rl values span a large region from 78 to 144 Mb (5q14.1–
5q32). This region has been reported numerous times previously. 
For example, this region harbors the gene PCSK1, common 
polymorphisms in the gene have been associated with obesity 
(10). The second marker included in our study from this region, 
D5S1725 (with an rl value of 2.37), was previously found to be 
linked to body fat and fat mass with lod scores of 2.56 and 2.25, 
respectively (34). It is worth mentioning that the study cohort 
consisted of 321 sibpairs from Western Africa. However, in two 
different linkage studies among white families, markers in this 
region, including D5S1505, which is included in our analysis, 
have been found to be linked with more direct BMI-related 
traits (27,35,36). Chen et al. (27)  analyzed 342  sibships and 
found D5S1453 at 5q21.3 to be linked with trends in BMI from 
childhood to adulthood with a lod score of 2 and D5S1505 to 
be linked with long-term burden in BMI with a lod score of 2.2. 
The above mentioned study (35) included 447 French subjects 
in 109 pedigrees chosen through a proband with BMI >27. They 
found a linkage peak with lod score 2.68 at marker D5S1463, 
located at 5q14.3. Rice et al. (36) studied abdominal fat and high 
BMI, involving 453 subjects in 99 white families, and found two 
peaks in this region. Of these two locations, marker D5S658 at 
5q31.3 had a lod score of 2.06 and D5S1480 had a lod score of 
2.1. In another study involving 88 families, BMI was shown to 
be associated with polymorphisms in the gene nuclear recep-
tor subfamily 3, group C, member 1 (glucocorticoid receptor) 
(NR3C1) at 5q31 with a P value of 0.009 (ref. 37).
The markers of chromosome 3, D3S2418 and D3S1311, 
spanning a 5 Mb region, show the strongest excess European 
ancestry with BMI in our study. Associations of markers in 
the candidate gene apolipoprotein D (3q26.2–qter) with BMI 
was reported by Vijayaraghavan et al. (38). Marker D3S1311, 
which was statistically significant after the permutation test, 
also lies in a promising linkage region (lod score 2.5) in the 
study of Rice et al. (36).
The region 15q25.3–15q26.3 harbors the two markers 
(D15S652 and D15S816) with the most significant rl  values 
in our study. It is also the site for the gene neuromedin B 
(NMB) (15q22–qter) which is a candidate for type 1  diabetes, 
 obesity, and hunger disorder (39). Polymorphisms in NMB 
have been shown to be associated with BMI and other obesi-
ty-related phenotypes (40). In a recent study, Bouchard et al. 
(41) fine mapped a 20-Mb region around a quantitative trait 
locus on chromosome 15q26 for abdominal  subcutaneous 
fat in an extended sample of 707 subjects from 202 families 
from the Quebec Family Study. Chagnon et al. (39)  studied 
336 sibpairs and 609 relative pairs and found D15S652 
linked with fat free mass with a lod score of 3.56. Another 
marker in this region, D15S657 at 15q26.2, also had a lod 
score of 2. Using a subset of the data that we have analyzed 
here, Lewis et al. (42) have reported linkage (lod score 3) 
of body fat (%) with marker D15S655 among men in the 
HyperGEN network.
Although our results have identified specific locations that 
may harbor genes influencing the trait BMI, they cannot indi-
cate the precise mechanism for the association. Specifically, 
they may represent genetic differences between Africans and 
Europeans in lean mass and bone content, or for patterns of fat 
accumulation. Because we did not have specific measures for 
these associated traits, we could not dissect more directly the 
source of the association.
We also note that obesity (or BMI) is a complex trait and it 
can respond to differential environmental influences. Though 
our study consists only of AA individuals, we still note a 
 significant variation among networks indicating possible 
 heterogeneities in the sample. The absence of detailed data on 
environmental influences, like diet, and its possible interac-
tion with genetics influencing BMI are questions which are 
beyond the scope of this article.
To our knowledge, this is the largest quantitative admixture 
mapping effort in terms of sample size and marker locus involve-
ment for the trait. We took care to eliminate possible errors in 
the locus-wise ancestry estimates, because any systematic bias 
could affect the final results. Statistical variation in locus-wise 
ancestry estimates was kept to a minimum by running the 
MCMC for a long period. To further check the robustness of our 
results, we also examined results of analyses based on  different 
random selections of unrelated individuals from the AA fami-
lies and obtained very similar results. Overall our  findings are 
encouraging and provide regions for follow-up analyses of genes 
influencing BMI in these and other AA families.
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